000 01459 a2200421 4500
005 20250512233404.0
264 0 _c19820814
008 198208s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aSessa, C
245 0 0 _aHexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
_h[electronic resource]
260 _bCancer treatment reports
_cMay 1982
300 _a1233-4 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAltretamine
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Evaluation
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aTriazines
_xadministration & dosage
700 1 _aD'Incalci, M
700 1 _aValente, I
700 1 _aBolis, G
700 1 _aColombo, N
700 1 _aMangioni, C
773 0 _tCancer treatment reports
_gvol. 66
_gno. 5
_gp. 1233-4
999 _c6805700
_d6805700